George Bers, formerly vice president of systems biology at Beckman Coulter, has left the company, BioCommerce Week has learned.

Bers joined Beckman 2001 as president of the life sciences division.

John Wareham, chairman and CEO of Beckman Coulter, told BCW this week that Bers and the company parted by mutual agreement.

Bruce Wallace, vice president and director of the company’s Systems Biology Business Center, has taken over Bers’ duties, Wareham said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.